1. Aizawa, T., et al., Polyglycolic Acid Felt for Prevention of Frey Syndrome After Parotidectomy. Ann Plast Surg, 2018.
2. Aizawa, T., et al., Quaba Flap for Reconstruction after Cancer Resection of an Amputated Finger Stump. J Hand Microsurg, 2018. 10(2): p. 119-122.
3. Aizawa, T., et al., Approaches for Excision of Intramasseteric Nodules. J Craniofac Surg, 2019. 30(1): p. e92-e94.
4. Aizawa, T., et al., Sutureless Microvascular Anastomosis using Intravascular Stenting and Cyanoacrylate Adhesive. J Reconstr Microsurg, 2018. 34(1): p. 8-12.
5. Liu, J., et al., Immobilization stress causes oxidative damage to lipid, protein, and DNA in the brain of rats. Faseb j, 1996. 10(13): p. 1532-8.
6. Vaziri, N.D. and B. Rodriguez-Iturbe, Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat Clin Pract Nephrol, 2006. 2(10): p. 582-93.
7. Lipinski, B., Hydroxyl radical and its scavengers in health and disease. Oxid Med Cell Longev, 2011. 2011: p. 809696.
8. Kobayashi, M. and M. Yamamoto, Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal, 2005. 7(3-4): p. 385-94.
9. Motohashi, H. and M. Yamamoto, Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med, 2004. 10(11): p. 549-57.
10. 伊東, 健., Nrf2/Keap1 を介した酸化ストレス防御機構. 生化学, 2006. 78(2): p. 79-92.
11. 伊東, 健. and 真. 蝦名, 細胞の酸化ストレス耐性に関わるシグナル伝達系 Nrf2/Keap1 シグナリングと自己防衛機能. 化学と生物, 2012. 50(6): p. 423-429.
12. 勝岡, 史. and 雅. 山本, 【活性酸素・フリーラジカル機能と病態解明への新たなる展開:バイオスピンとシグナル伝達】Keap1-Nrf2 システムが担う生体防御機構. 細胞工学, 2006. 25(2): p. 153-156.
13. Yamamoto, S., et al., TRPM2-mediated Ca2+influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med, 2008. 14(7): p. 738-47.
14. Nakagawa, J., et al., The Beneficial Effects of ETS-GS, a Novel Vitamin E Derivative, on a Rat Model of Crush Injury. Shock, 2016. 46(6): p. 681-687.
15. Zhai, W., et al., Effect of free radical scavenger on c-jun activation in rats with crush syndrome. Int J Clin Pharmacol Ther, 2013. 51(7): p. 600-5.
16. Manson, P.N., et al., Evidence for an early free radical-mediated reperfusion injury in frostbite. Free Radic Biol Med, 1991. 10(1): p. 7-11.
17. Stadtman, E.R., Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem, 1993. 62: p. 797-821.
18. Granger, D.N., G. Rutili, and J.M. McCord, Superoxide radicals in feline intestinal ischemia. Gastroenterology, 1981. 81(1): p. 22-9.
19. Sussman, M.S. and G.B. Bulkley, Oxygen-derived free radicals in reperfusion injury. Methods Enzymol, 1990. 186: p. 711-23.
20. McCauley, R.L., et al., Frostbite injuries: a rational approach based on the pathophysiology. J Trauma, 1983. 23(2): p. 143-7.
21. Miller, M.B. and P.J. Koltai, Treatment of experimental frostbite with pentoxifylline and aloe vera cream. Arch Otolaryngol Head Neck Surg, 1995. 121(6): p. 678-80.
22. Mohr, W.J., K. Jenabzadeh, and D.H. Ahrenholz, Cold injury. Hand Clin, 2009. 25(4): p. 481-96.
23. Purdue, G.F. and J.L. Hunt, Cold injury: a collective review. J Burn Care Rehabil, 1986. 7(4): p. 331-42.
24. Su, C.W., R. Lohman, and L.J. Gottlieb, Frostbite of the upper extremity. Hand Clin, 2000. 16(2): p. 235-47.
25. Vogel, J.E. and A.L. Dellon, Frostbite injuries of the hand. Clin Plast Surg, 1989. 16(3): p. 565- 76.
26. Murphy, J.V., et al., Frostbite: pathogenesis and treatment. J Trauma, 2000. 48(1): p. 171-8.
27. Robson, M.C. and J.P. Heggers, Evaluation of hand frostbite blister fluid as a clue to pathogenesis. J Hand Surg Am, 1981. 6(1): p. 43-7.
28. Diamond, B.J., et al., Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil, 2000. 81(5): p. 668-78.
29. Lim, S., et al., EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes. PLoS One, 2011. 6(6): p. e20301.
30. Gohil, K. and L. Packer, Global gene expression analysis identifies cell and tissue specific actions of Ginkgo biloba extract, EGb 761. Cell Mol Biol (Noisy-le-grand), 2002. 48(6): p. 625-31.
31. Oken, B.S., D.M. Storzbach, and J.A. Kaye, The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol, 1998. 55(11): p. 1409-15.
32. Smith, J.V. and Y. Luo, Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimers Dis, 2003. 5(4): p. 287-300.
33. Iriti, M., et al., Neuroprotective herbs and foods from different traditional medicines and diets. Molecules, 2010. 15(5): p. 3517-55.
34. Zimmermann, M., et al., Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer's disease. Cell Mol Biol (Noisy-le-grand), 2002. 48(6): p. 613-23.
35. Smith, J.V. and Y. Luo, Studies on molecular mechanisms of Ginkgo biloba extract. Appl Microbiol Biotechnol, 2004. 64(4): p. 465-72.
36. Oyama, Y., et al., Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res, 1996. 712(2): p. 349-52.
37. Smith, P.F., K. Maclennan, and C.L. Darlington, The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J Ethnopharmacol, 1996. 50(3): p. 131-9.
38. Sierpina, V.S., B. Wollschlaeger, and M. Blumenthal, Ginkgo biloba. Am Fam Physician, 2003. 68(5): p. 923-6.
39. Luo, Y., et al., Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci U S A, 2002. 99(19): p. 12197-202.
40. Watanabe, C.M., et al., The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proc Natl Acad Sci U S A, 2001. 98(12): p. 6577-80.
41. 田中, 忍., et al., ラットにおける食後の血糖上昇に及ぼすイチョウ葉由来フラボノイドフラクションの抑制作用. 薬学雑誌, 2004. 124(9): p. 605-611.
42. Tchantchou, F., et al., EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease. Faseb j, 2007. 21(10): p. 2400-8.
43. Hamann, K.F., [Special ginkgo extract in cases of vertigo: a systematic review of randomised, double-blind, placebo controlled clinical examinations]. Hno, 2007. 55(4): p. 258-63.
44. Sokolova, L., R. Hoerr, and T. Mishchenko, Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine. Int J Otolaryngol, 2014. 2014: p. 682439.
45. Hilton, M.P., E.F. Zimmermann, and W.T. Hunt, Ginkgo biloba for tinnitus. Cochrane Database Syst Rev, 2013(3): p. Cd003852.
46. Tziridis, K., et al., Protective effects of Ginkgo biloba extract EGb 761 against noise trauma- induced hearing loss and tinnitus development. Neural Plast, 2014. 2014: p. 427298.
47. Unger, M., Pharmacokinetic drug interactions involving Ginkgo biloba. Drug Metab Rev, 2013. 45(3): p. 353-85.
48. Wang, J., et al., Supervised exercise training combined with ginkgo biloba treatment for patients with peripheral arterial disease. Clin Rehabil, 2007. 21(7): p. 579-86.
49. Liu, Q., et al., Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo. Cell Stress Chaperones, 2019. 24(2): p. 441-452.
50. Guo, L., et al., Ginkgo biloba extract induces gene expression changes in xenobiotics metabolism and the Myc-centered network. Omics, 2010. 14(1): p. 75-90.
51. Hsu, C.L., et al., Ginkgo biloba extract confers protection from cigarette smoke extract-induced apoptosis in human lung endothelial cells: Role of heme oxygenase-1. Pulm Pharmacol Ther, 2009. 22(4): p. 286-96.
52. Chen, J.S., et al., Nrf-2 mediated heme oxygenase-1 expression, an antioxidant-independent mechanism, contributes to anti-atherogenesis and vascular protective effects of Ginkgo biloba extract. Atherosclerosis, 2011. 214(2): p. 301-9.
53. Nada, S.E. and Z.A. Shah, Preconditioning with Ginkgo biloba (EGb 761(R)) provides neuroprotection through HO1 and CRMP2. Neurobiol Dis, 2012. 46(1): p. 180-9.
54. Chen, X.J., et al., Ginkgo biloba extract-761 protects myocardium by regulating Akt/Nrf2 signal pathway. Drug Des Devel Ther, 2019. 13: p. 647-655.
55. Zhang, S., et al., Ginkgo biloba extract protects human melanocytes from H2 O2 -induced oxidative stress by activating Nrf2. J Cell Mol Med, 2019. 23(8): p. 5193-5199.
56. 和田, 貴., 厚. 村田, and 修. 島崎, 【プライマリケア医のための創傷治療ガイド】 凍傷 frostbite. 治療, 2003. 85(10): p. 2787-2793.
57. Goertz, O., et al., Determination of microcirculatory changes and angiogenesis in a model of frostbite injury in vivo. J Surg Res, 2011. 168(1): p. 155-61.
58. Sarikaya, I., et al., Assessment of tissue viability after frostbite injury by technetium-99m-sestamibi scintigraphy in an experimental rabbit model. Eur J Nucl Med, 2000. 27(1): p. 41-5.
59. Ozyazgan, I., et al., Defibrotide activity in experimental frostbite injury. Br J Plast Surg, 1998. 51(6): p. 450-4.
60. Arvesen, A., et al., Early and late functional and histopathological perturbations in the rabbit ear- artery following local cold injury. Vasa, 1999. 28(2): p. 85-94.
61. Auerbach, L.J., et al., A novel mouse model for frostbite injury. Wilderness Environ Med, 2013. 24(2): p. 94-104.
62. Delgado-Martinez, J., et al., Skin coverage in frostbite injuries: experimental study. J Plast Reconstr Aesthet Surg, 2010. 63(10): p. e713-9.
63. Marzella, L., et al., Morphologic characterization of acute injury to vascular endothelium of skin after frostbite. Plast Reconstr Surg, 1989. 83(1): p. 67-76.
64. Zook, N., et al., Microcirculatory studies of frostbite injury. Ann Plast Surg, 1998. 40(3): p. 246- 53; discussion 254-5.
65. Bekerecioglu, M., M. Tercan, and I. Ozyazgan, The effect of Gingko biloba extract (Egb 761) as a free radical scavenger on the survival of skin flaps in rats. A comparative study. Scand J Plast Reconstr Surg Hand Surg, 1998. 32(2): p. 135-9.
66. Sambuy, M.T., et al., Effect of Ginkgo biloba extract (GbE-761) on the survival of fasciocutaneous flaps in rats. Phytother Res, 2012. 26(2): p. 299-302.
67. Kawai, S., et al., Effect of three types of mixed anesthetic agents alternate to ketamine in mice. Exp Anim, 2011. 60(5): p. 481-7.
68. Bosch, R.V., et al., Hemolin triggers cell survival on fibroblasts in response to serum deprivation by inhibition of apoptosis. Biomed Pharmacother, 2016. 82: p. 537-46.
69. Joseph, L.B., et al., Structural changes in the skin of hairless mice following exposure to sulfur mustard correlate with inflammation and DNA damage. Exp Mol Pathol, 2011. 91(2): p. 515-27.
70. Mao, X.W., et al., Low-dose radiation modifies skin response to acute gamma-rays and protons. In Vivo, 2013. 27(6): p. 695-700.
71. Ono, I., et al., Combined administration of basic fibroblast growth factor protein and the hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds. Wound Repair Regen, 2004. 12(1): p. 67-79.
72. Ono, I., et al., Local administration of hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds. J Surg Res, 2004. 120(1): p. 47-55.
73. Piao, M.J., et al., Phloroglucinol inhibits ultraviolet B radiation-induced oxidative stress in the mouse skin. Int J Radiat Biol, 2014. 90(10): p. 928-35.
74. Solmaz, A., et al., Nesfatin-1 improves oxidative skin injury in normoglycemic or hyperglycemic rats. Peptides, 2016. 78: p. 1-10.
75. Takikawa, M., et al., Protective effect of prostaglandin E(1) on radiation-induced proliferative inhibition and apoptosis in keratinocytes and healing of radiation-induced skin injury in rats. J Radiat Res, 2012. 53(3): p. 385-94.
76. Xiao, M., et al., Role of autophagy and apoptosis in wound tissue of deep second-degree burn in rats. Acad Emerg Med, 2014. 21(4): p. 383-91.
77. Xie, P., et al., Systemic administration of hemoglobin improves ischemic wound healing. J Surg Res, 2015. 194(2): p. 696-705.
78. Davidson, J.M., Animal models for wound repair. Arch Dermatol Res, 1998. 290 Suppl: p. S1-11.
79. Greenhalgh, D.G., Models of wound healing. J Burn Care Rehabil, 2005. 26(4): p. 293-305.
80. Toyokuni, S., et al., Induction of a wide range of C(2-12) aldehydes and C(7-12) acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med, 1997. 22(6): p. 1019-27.
81. Uchida, K. and E.R. Stadtman, Modification of histidine residues in proteins by reaction with 4- hydroxynonenal. Proc Natl Acad Sci U S A, 1992. 89(10): p. 4544-8.
82. Toyokuni, S., et al., The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett, 1995. 359(2-3): p. 189-91.
83. Hattori, Y., et al., 8-hydroxy-2'-deoxyguanosine is increased in epidermal cells of hairless mice after chronic ultraviolet B exposure. J Invest Dermatol, 1996. 107(5): p. 733-7.
84. Liu, Y., et al., Hydrogen saline offers neuroprotection by reducing oxidative stress in a focal cerebral ischemia-reperfusion rat model. Med Gas Res, 2011. 1(1): p. 15.
85. Terasaki, Y., et al., Hydrogen therapy attenuates irradiation-induced lung damage by reducing oxidative stress. Am J Physiol Lung Cell Mol Physiol, 2011. 301(4): p. L415-26.
86. Toyokuni, S., et al., Quantitative immunohistochemical determination of 8-hydroxy-2'- deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate- induced renal carcinogenesis model. Lab Invest, 1997. 76(3): p. 365-74.
87. Yarborough, A., et al., Immunoperoxidase detection of 8-hydroxydeoxyguanosine in aflatoxin B1- treated rat liver and human oral mucosal cells. Cancer Res, 1996. 56(4): p. 683-8.
88. Inafuku, H., et al., Determination of oxidative stress and cardiac dysfunction after ischemia/reperfusion injury in isolated rat hearts. Ann Thorac Cardiovasc Surg, 2013. 19(3): p. 186-94.
89. Aizawa, T., et al., Protective Effect of Extract of Ginkgo biloba 761 against Frostbite Injury in Rats. Plast Reconstr Surg, 2019. 143(6): p. 1657-1664.
90. Drago, F., et al., Pharmacokinetics and bioavailability of a Ginkgo biloba extract. J Ocul Pharmacol Ther, 2002. 18(2): p. 197-202.
91. Wang, J., et al., Transcriptional upregulation centra of HO-1 by EGB via the MAPKs/Nrf2 pathway in mouse C2C12 myoblasts. Toxicol In Vitro, 2015. 29(2): p. 380-8.
92. Kim, Y.S., et al., Antiplatelet and antithrombotic effects of a combination of ticlopidine and ginkgo biloba ext (EGb 761). Thromb Res, 1998. 91(1): p. 33-8.
93. Bone, K.M., Potential interaction of Ginkgo biloba leaf with antiplatelet or anticoagulant drugs: what is the evidence? Mol Nutr Food Res, 2008. 52(7): p. 764-71.
94. Jones, L.M., et al., The use of intravenous tPA for the treatment of severe frostbite. Burns, 2017. 43(5): p. 1088-1096.
95. Twomey, J.A., G.L. Peltier, and R.T. Zera, An open-label study to evaluate the safety and efficacy of tissue plasminogen activator in treatment of severe frostbite. J Trauma, 2005. 59(6): p. 1350-4; discussion 1354-5.
96. Wexler, A. and S. Zavala, The Use of Thrombolytic Therapy in the Treatment of Frostbite Injury. J Burn Care Res, 2017. 38(5): p. e877-e881.